Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients [0.03%]
造血干细胞和实体器官移植受者早期艰难梭菌感染的特征、风险及结局
Karam M Obeid,Smarika Sapkota,Qing Cao et al.
Karam M Obeid et al.
Background: Clostridioides difficile infection (CDI) frequently complicates allogeneic hematopoietic stem cell (allo-HCT) and solid organ transplantation (SOT). ...
Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant [0.03%]
抗胸腺细胞globulin预处理的异基因造血细胞移植后移植物抗宿主病中Epstein-Barr病毒感染的动力学变化
Julian Lindsay,Jad Othman,Michelle K Yong et al.
Julian Lindsay et al.
Background: The use of antithymocyte globulin (ATG) in allogeneic hematopoietic cell transplant (HCT) is associated with an increased risk of Epstein-Barr virus (EBV) reactivation and post-transplant lymphoproliferative d...
Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non-relapse mortality after allogeneic hematopoietic stem cell transplantation [0.03%]
同种异体造血干细胞移植后巨细胞病毒再活化动力学（以巨细胞病毒抗原血症面积下方面积表示）与非复发死亡率之间的关系
Junko Takeshita,Shun-Ichi Kimura,Hideki Nakasone et al.
Junko Takeshita et al.
Background: We assessed the kinetics of cytomegalovirus (CMV) reactivation using the area under the curve (AUC), which simultaneously reflects both the viral load at each time point and the duration of CMV antigenemia (CM...
Pseudomonal blepharoconjunctivitis causing neutropenic sepsis after allogeneic hematopoietic cell transplantation [0.03%]
异基因造血细胞移植后粒细胞缺乏性脓毒血症所致假单胞菌结膜炎
Ziyang Xu,Enny O Oyeniran,Xiaowei Xu et al.
Ziyang Xu et al.
Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients [0.03%]
心脏移植受者早发性侵袭性真菌感染的流行病学、危险因素及抗真菌预防的相关性
Zachary A Yetmar,Brian Lahr,Lisa Brumble et al.
Zachary A Yetmar et al.
Background: Invasive fungal infection (IFI) in heart transplant recipients is associated with poor outcomes. Estimated risk of 1-year IFI in heart transplant recipients is 3.4-8.6% with risk factors inconsistently identif...
Impact of broad-spectrum antibiotic exposures and multidrug-resistant gram-negative bacteremia on hematopoietic cell transplantation outcomes [0.03%]
广谱抗生素暴露和多重耐药革兰氏阴性杆菌血流感染对造血细胞移植结局的影响
Shaweta Kaundal,Aditya Jandial,Harmandeep Singh et al.
Shaweta Kaundal et al.
Introduction: There is a close association between the use of broad-spectrum antibiotics, gut microbiome alteration, multidrug resistant (MDR) gram-negative bacilli (GNB) bacteremia, graft versus host disease (GVHD), and ...
Comparison of standard versus low-dose valganciclovir regimens for cytomegalovirus prophylaxis in high-risk liver transplant recipients [0.03%]
高风险肝移植受者更适于接受标准剂量还是低剂量缬加昔洛韦预防巨细胞病毒感染？一项系统综述和meta分析
Alexandra L Bixby,Linda Fitzgerald,Jeong M Park et al.
Alexandra L Bixby et al.
Purpose: The purpose of this study was to compare the safety and efficacy of two valganciclovir (VGCV) institutional dosing protocols for cytomegalovirus (CMV) prophylaxis in liver transplant (LT) recipients with CMV sero...
Effect of glecaprevir/pibrentasvir on weight-adjusted tacrolimus trough/dose ratios in heart and kidney transplant recipients [0.03%]
glecaprevir/pibrentasvir对心脏和肾脏移植受者校正体重的他克莫司谷/剂量比的影响
Daryl U Nnani,Alesa Campbell,Maria Ajaimy et al.
Daryl U Nnani et al.
Objective: The pharmacokinetic implications of direct-acting antiviral (DAA) use on tacrolimus posttransplant are unknown. This study sought to investigate the effects of glecaprevir/pibrentasvir (G/P), a CYP3A4 substrate...
Rujittika Mungmunpuntipantip,Viroj Wiwanitkit
Rujittika Mungmunpuntipantip
Evaluation of low dose famciclovir as herpes simplex virus and varicella zoster virus prophylaxis in cytomegalovirus low-risk solid organ transplant recipients [0.03%]
评估泛昔洛韦小剂量用于CMV低风险器官移植受者HSV和VZV的预防效力
Ashley Crouch,Mariesa Le,Christin Rogers et al.
Ashley Crouch et al.
Objective: Famciclovir is a recommended option for herpes simplex virus (HSV) and varicella-zoster virus (VZV) prophylaxis in cytomegalovirus (CMV) low-risk solid organ transplant (SOT) recipients in current guidelines; h...